Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)

[1]  A. Valachis,et al.  Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis , 2016, Acta oncologica.

[2]  M. Ellis,et al.  Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial) , 2015, Breast Cancer Research and Treatment.

[3]  G. Sledge,et al.  Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103 , 2014, Breast Cancer Research and Treatment.

[4]  E. Perez,et al.  Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Singletary,et al.  Incidence and time course of bleeding after long‐term amenorrhea after breast cancer treatment , 2010, Cancer.

[6]  E. Perez,et al.  Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. , 2010, The New England journal of medicine.

[7]  S. Missmer,et al.  The effects of paclitaxel, dose density, and trastuzumab on treatment‐related amenorrhea in premenopausal women with breast cancer , 2010, Cancer.

[8]  E. Lee,et al.  Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer , 2009, Breast Cancer Research and Treatment.

[9]  J. Costantino,et al.  Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial , 2008, Breast Cancer Research and Treatment.

[10]  E. Winer,et al.  Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. , 2007, European journal of cancer.

[11]  S. Swain,et al.  Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Bonetti,et al.  Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. , 2003, Journal of the National Cancer Institute.